Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2020-04-07 Capital/Financing Update
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Episurf Medical announces outcome of preferential rights issue
Capital/Financing Update Classification · 1% confidence The document is titled "Episurf Medical announces outcome of preferential rights issue." It details the results of a rights issue, including the amount of proceeds received (SEK 51m), the number of shares subscribed for, and the resulting increase in share capital. This content directly relates to a company's fundraising and capital structure change. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA), but rather the substantive announcement of the financing event itself.
2020-04-07 English
SUMMARY FROM ANNUAL GENERAL MEETING OF EPISURF MEDICAL AB (PUBL)
AGM Information Classification · 1% confidence The document explicitly states in the main heading that it is a "SUMMARY FROM ANNUAL GENERAL MEETING OF EPISURF MEDICAL AB (PUBL)". The content details resolutions passed regarding the approval of financial statements, re-election of the Board of Directors, auditor appointment, approval of remuneration guidelines, and adoption of an incentive program involving warrants and options. These are all typical outcomes and summaries presented immediately following an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2020-04-02 English
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I EPISURF MEDICAL AB (PUBL)
AGM Information Classification · 1% confidence The document is titled "KOMMUNIKÉ FRÅN ÅRSSTÄMMA I EPISURF MEDICAL AB (PUBL)" which translates to "COMMUNIQUÉ FROM THE ANNUAL GENERAL MEETING IN EPISURF MEDICAL AB (PUBL)". The text details decisions made at the Annual General Meeting (Årsstämma), including the approval of financial statements, election/re-election of board members and the chairman, auditor appointment (KPMG AB), approval of remuneration, and crucially, the resolution to implement an incentive program involving the issuance of warrants (teckningsoptioner) and performance options. Since the document reports the outcomes and decisions made during the AGM, it directly relates to the proceedings of that meeting. This aligns perfectly with the definition for AGM Information (AGM-R). It is not a proxy statement (PSI) as it reports the results, nor is it a general earnings release (ER) or a full annual report (10-K).
2020-04-02 Swedish
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly details a change in shareholding ('Resulting distribution of total holdings', 'Group total holdings') by a major holder ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension') and references a 'Limit for number of shares' and 'Limit for number of votes' (5%). This structure, reporting changes in ownership that cross specific percentage thresholds, directly corresponds to a Major Shareholding Notification. The filing type code for this is MRQ.
2020-04-01 English
Change in number of shares and votes in Episurf Medical
Share Issue/Capital Change Classification · 1% confidence The document explicitly details a 'Change in number of shares and votes' following a directed share issue. It quantifies the increase in B-shares, the total number of shares (A and B), the total number of votes, and the resulting increase in share capital. This directly relates to changes in the company's capital structure through the issuance of new shares. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). The document is short and appears to be a formal regulatory announcement regarding this specific event.
2020-03-31 English
Förändring av antalet aktier och röster i Episurf Medical
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly details a change in the total number of shares and votes following a directed share issue ('riktad nyemission'). It specifies the increase in A-shares and B-shares, the new total share count (144,264,088), the resulting total votes (146,206,136), and the increase in share capital. This content directly relates to changes in the company's capital structure due to new share issuance, which aligns perfectly with the definition of 'Share Issue/Capital Change' (SHA). The final sentence confirms it is regulatory information being made public, but the core subject matter is the capital change itself.
2020-03-31 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.